Suppr超能文献

热点探测的热扫描:配体和结构独立评估靶标可成药性。

Hot-Spotting with Thermal Scanning: A Ligand- and Structure-Independent Assessment of Target Ligandability.

机构信息

Innovative Medicines and Early Development Biotech Unit, Discovery Sciences, AstraZeneca R&D Gothenburg , 43183 Mölndal, Sweden.

出版信息

J Med Chem. 2017 Jun 22;60(12):4923-4931. doi: 10.1021/acs.jmedchem.7b00208. Epub 2017 Jun 2.

Abstract

Evaluating the ligandability of a protein target is a key component when defining hit-finding strategies or when prioritize among drug targets. Computational as well as biophysical approaches based on nuclear magnetic resonance (NMR) fragment screening are powerful approaches but suffer from specific constraints that limit their usage. Here, we demonstrate the applicability of high-throughput thermal scanning (HTTS) as a simple and generic biophysical fragment screening method to reproduce assessments from NMR-based screening. By applying this method to a large set of proteins we can furthermore show that the assessment is predictive of the success of high-throughput screening (HTS). The few divergences for targets of low ligandability originate from the sensitivity differences of the orthogonal biophysical methods. We thus applied a new strategy making use of modulations in the solvent structure to improve assay sensitivity. This novel approach enables improved ligandability assessments in accordance with NMR-based assessments and more importantly positions the methodology as a valuable option for biophysical fragment screening.

摘要

评估蛋白质靶标的配体结合能力是定义命中发现策略或在药物靶标中进行优先级排序的关键组成部分。基于核磁共振 (NMR) 片段筛选的计算和生物物理方法是强大的方法,但受到限制其使用的特定限制。在这里,我们证明了高通量热扫描 (HTTS) 作为一种简单而通用的生物物理片段筛选方法的适用性,可重现基于 NMR 的筛选的评估。通过将该方法应用于大量蛋白质,我们还可以证明该评估可预测高通量筛选 (HTS) 的成功。对于低配体结合能力的靶标,少数差异源自正交生物物理方法的灵敏度差异。因此,我们应用了一种新策略,利用溶剂结构的调制来提高测定灵敏度。这种新方法能够根据基于 NMR 的评估进行改进的配体结合能力评估,更重要的是,将该方法定位为生物物理片段筛选的有价值选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验